A Randomized, Double-Blind, Placebo Controlled Study of Zileuton CR Tablets Versus Placebo in Adult Patients With Poorly Controlled Asthma Patients on Moderate Dose Inhaled Corticosteroids (ICS)
Phase of Trial: Phase IV
Latest Information Update: 02 Apr 2008
At a glance
- Drugs Zileuton (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 02 Apr 2008 The estimated date of final data collection for the primary endpoint has changed from June 2008 to May 2008 according to ClinicalTrials.gov.
- 31 Mar 2008 Status change from recruiting to discontinued according to a media release from Critical Therapeutics.
- 10 Jan 2008 The expected completion date for this trial is now 1 Jun 2008.